Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-23

FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for IMITREX (sumatriptan) submitted by GlaxoSmithKline LLC. The approval updates the product labeling or indication as d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imitrex (Sumatriptan)

Snippet

SUPPL AP for IMITREX (SUMATRIPTAN)